1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
iRay Technology Company Limited Class A

iRay Technology Company Limited Class A

SSSE:688301
71.30
CNY
-4.05
(-5.37%)
38.70BMarket Cap
Oct 30Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.02
1.23
1.76
2.1
2.61
3.46
4.26
5.55
6.67
6.55
7.91
- -
Basic EPS, GAAP
0.09
0.2
0.27
0.29
0.46
0.98
1.74
2.3
2.17
1.66
2.29
- -
Free Cash Flow per Basic Share
- -
- -
0.32
-0.14
-0.04
1.08
0.2
-1.44
-5.41
-3.87
-1.35
- -
Dividend per Share
0.14
- -
- -
- -
- -
0.01
0.26
0.58
0.78
0.92
0.76
0.93
Book Value per Share
0.65
0.85
1.2
1.58
2.04
9.45
10.95
13.88
15.47
16.54
20.95
24.79
Tangible Book Value per Share
0.6
0.8
1.16
1.53
1.99
9.41
10.78
12.97
14.56
15.44
19.65
23.57
Basic Weighted Avg Shares
209
209
203
210
209
226
279
279
280
280
284
293
Sales/Revenue/Turnover
213
256
356
439
546
784
1,187
1,549
1,864
1,831
2,251
- -
Operating Margin (%)
8.03
18.11
18.64
13.82
18.92
31.45
36.25
36.07
38.59
28.67
29.79
- -
Depreciation Expense
- -
- -
5
12
16
24
32
50
56
73
148
- -
Net Income, GAAP
19
43
54
61
96
222
484
641
607
465
650
- -
Effective Tax Rate (%)
20.3
13.35
15.92
12
7.43
12.27
13.46
9.88
11.71
11.21
7.8
- -
Profit Margin (%)
8.89
16.72
15.28
13.79
17.65
28.34
40.77
41.4
32.59
25.4
28.88
- -
Working Capital
116
144
178
219
280
2,487
2,670
4,005
2,351
3,054
3,375
4,145
LT Debt
- -
- -
- -
- -
- -
12
8
1,302
1,718
3,407
3,802
3,143
Total Equity
135
178
251
331
426
2,634
3,077
3,904
4,353
4,646
6,668
8,200
Return on Invested Capital (%)
- -
24.2
24.61
18.26
21.98
13.82
16.2
14.96
10.17
6.12
6.55
- -
Return on Capital (%)
- -
27.36
25.27
21.27
24.47
14
16.55
15.41
10.71
6.87
7.22
- -
Return on Common Equity (%)
- -
27.36
25.33
20.86
25.53
14.53
17.03
18.51
14.8
10.37
11.99
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
501
261
415
LT Borrowings
3,716
4,410
3,064
LT Finance Leases
85
89
79
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
296
296
312
Market Capitalization
21,380
22,982
38,700

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,482
5,909
5,883
Cash, Cash Equivalents & STI
3,657
3,814
3,682
Accounts Receivable, Net
722
833
1,016
Inventories
822
918
901
Total Current Liabilities
2,107
1,622
1,738
Payables & Accruals
- -
- -
- -
ST Debt
501
261
415
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
75.77%
21.09%
43.51%
Free Cash Flow
- -
-140.8%
-64.43%
Net Income, GAAP
51.54%
32.26%
39.73%
Sales/Revenue/Turnover
27.39%
24.67%
22.9%
Total Cash Common Dividend
- -
512.71%
-16.4%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
491
535
330
475
1,831
2025
482
585
- -
702
2,251
2026
686
985
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.5
0.6
0.3
0.27
1.66
2025
0.51
0.68
- -
0.61
2.29
2026
0.6
0.76
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.79
0.04
0.03
0.92
2025
0.07
0.56
- -
0.07
0.76
2026
0.06
0.78
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Tie Gu
Full Time Employees
2,292
Sector
Health technology
Industry
Medical specialties
Address
No.999, Huanqiao Road Shanghai SH China 201315
IPO Date
Sep 14, 2020
Website
iraygroup.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
iRay Group (688301.SS) develops, manufactures and sells flat panel X-ray detectors and related components for medical, dental, veterinary, security and industrial imaging applications in China and internationally. The company offers wireless radiography detectors including a-Si cassette and flexible cassette models; tethered radiography detectors; mammography detectors; dynamic/real-time detectors; linear detector arrays; X-ray sources; high voltage generators; X-ray tubes; radiation detecting materials; and related software solutions. iRay Group operates production facilities in Taicang, Haining, Hefei and Chengdu in China, as well as in Seoul, Korea and Cleveland, USA, with products deployed in over 80 countries and an installed base exceeding 300,000 units; its technology portfolio encompasses amorphous silicon (a-Si), oxide TFT, flexible substrates and CMOS devices. Founded in 2011 and headquartered in Shanghai, China, the company, formerly iRay Technology Company Limited, changed its name to iRay Group in February 2025. Recent developments include the completion of its Hefei production base and U.S. factory operations to support a global layout of one headquarters plus six bases; a CNY 600 million equity investment in subsidiary IRay Imaging Technology (Hefei) Co., Ltd. in May 2025 with iRay Group retaining majority stake; issuance of 11,048,980 shares raising CNY 1.17 billion in September 2025 from investors including Guangdong Hengkuo and Hubei Hongtai; and active expansion into new core components such as high-voltage generators, X-ray tubes and integrated radiation sources, with products entering batch delivery to major customers.